EDVA Endovia Health Sciences, Inc.
Beverages · NYSE · SEC CIK 1553788 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY79.3%
TTM net income YoY33.3%
TTM EPS YoY89.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin-13.6%
Operating margin3,741.9%
Net margin4,787.7%
FCF margin—
EBITDA margin3,756.9%
Returns
ROE—
ROA-148.3%
ROIC (approx.)—
Asset turnover-0.03x
Leverage & solvency
Liabilities / assets1,563.2%
Debt / equity—
Current ratio0.05x
Interest coverage-5.67x
Cash quality & payout
Operating cash flow / net income0.31x
Accruals ratio-101.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q2*2026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q3*2025-09-30 | 2025Q2*2025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $0 | $4,224 | -$365,206 | $0 | -$23,406 | $68,606 | -$2.77M | $981,859 |
| Cost of revenue | — | — | — | $0 | $0 | $468,715 | $929,502 | $690,839 |
| Gross profit | $0 | $1,848 | $47,341 | $0 | -$32,146 | $25,544 | -$343,614 | $291,019 |
| SG&A expense | — | — | — | — | — | — | — | $55,000 |
| Operating income | -$2.01M | -$978,970 | -$976,411 | -$9.54M | -$1.50M | -$1.66M | -$6.44M | -$2.67M |
| Interest expense | $231,020 | $889,455 | $940,855 | $320,013 | $625,047 | $637,345 | $1.66M | $890,471 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$2.05M | -$2.14M | -$3.21M | -$9.89M | -$8.49M | -$3.65M | -$9.04M | -$4.72M |
| EBITDA | -$2.00M | -$976,649 | -$1.08M | -$9.51M | -$1.46M | -$1.66M | -$6.44M | -$2.63M |
| EPS (basic) | — | -0.47 | — | — | — | -1.97 | — | — |
| EPS (diluted) | — | -0.47 | — | — | — | -1.97 | — | — |
| Weighted avg. shares (diluted) | 3.06M | 4.57M | — | 2.19M | 474,969 | 1.86M | — | 1.31M |
| Banking | ||||||||
| Net interest income | $57,156 | -$889,455 | -$940,855 | -$320,013 | -$625,047 | -$637,345 | -$1.66M | -$889,734 |
| Balance sheet | ||||||||
| Cash & equivalents | $242,702 | $381,195 | $281,435 | $265,667 | $17,213 | — | $15,346 | $456,887 |
| Receivables | $14,316 | $20,333 | $15,748 | $139,504 | $140,626 | $172,819 | $191,991 | $595,305 |
| Inventory | $54,922 | $54,922 | $33,538 | $855,326 | $855,326 | $861,053 | $319,104 | $1.34M |
| Current assets | $900,407 | $708,848 | $631,993 | $1.97M | $1.61M | $1.69M | $1.90M | $3.04M |
| PP&E, net | — | $10,605 | $12,926 | $93,756 | $130,773 | $167,791 | $22,210 | $241,766 |
| Goodwill | — | — | — | — | — | — | — | $256,823 |
| Intangibles | — | — | — | — | — | — | — | $4.17M |
| Total assets | $1.08M | $769,953 | $965,694 | $22.49M | $22.24M | $2.51M | $2.76M | $8.36M |
| Current liabilities | $16.83M | $16.97M | $16.26M | $15.64M | $13.45M | $20.42M | $19.37M | $17.78M |
| Long-term debt | — | $857 | $3,418 | $58,130 | $52,534 | $2.08M | $1.97M | $1.32M |
| Total debt | — | $857 | $3,418 | $58,130 | $52,534 | $2.08M | $1.97M | $1.32M |
| Total liabilities | $16.83M | $16.97M | $16.27M | $15.71M | $13.52M | $22.54M | $21.39M | $19.19M |
| Shareholders' equity | -$15.75M | -$16.20M | -$15.30M | $6.78M | $8.72M | -$20.03M | -$18.63M | -$10.83M |
| Net debt | — | -$380,338 | -$278,017 | -$207,537 | $35,321 | — | $1.96M | $865,983 |
| Shares outstanding | 749,450 | 3.00M | 749,450 | 1.67M | 1.67M | 1.90M | 1.67M | 44.33M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.09M | -$930,492 | -$991,221 | -$2.42M | -$551,123 | -$808,046 | -$1.62M | -$2.65M |
| Capital expenditure | — | — | — | — | — | — | $0 | — |
| Free cash flow | — | — | — | — | — | — | -$1.62M | — |
| Investing cash flow | — | — | — | — | — | — | $0 | -$4,735 |
| Financing cash flow | $1.16M | $1.05M | $977,842 | $2.67M | $696,356 | $755,810 | $1.16M | $3.01M |
| Depreciation & amortization | $8,284 | $2,321 | -$101,769 | $37,017 | $37,017 | $2,321 | -$3,720 | $37,017 |
| Stock-based compensation | $1.11M | $176,972 | $677,328 | $7.75M | $53,859 | $135,709 | $271,013 | $186,682 |
Free plan shows the latest 8 periods; Pro shows all 58 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.